Muscle Opiate Receptors: The Science Behind It

do muscles have opiate receptors

Opioid receptors are widely distributed in the human body and are involved in numerous physiological processes, including pain signalling in the central and peripheral nervous systems, reproduction, growth, respiration, and immunological response. They are also present in the gastrointestinal (GI) tract, where they play a role in physiological and pathophysiological conditions. Opioids and their receptors are inhibitory, meaning they dampen electric pulses in our nerves rather than sparking them. Opioid receptors have been found in neural tissue in the rat enteric nervous system (ENS) and isolated mammalian gastric smooth muscle cells, but not in smooth muscle cells. This raises the question: do muscles have opiate receptors?

Characteristics Values
Opioid receptors Mu, Kappa, and Delta
Opioid receptor subtypes μ, δ, and κ
Opioid receptor functions Pain signaling, reproduction, growth, respiration, and immunological response
Opioid receptor locations Central and peripheral nervous system, gastrointestinal tract
Opioid receptor involvement in muscle contraction Studies have shown the presence of opioid receptors in isolated mammalian gastric smooth muscle cells and their direct contractile action
Opioid receptor involvement in addiction Opioid receptors govern more than just pain pathways; they are involved in addiction and dependence
Opioid receptor modulation Allosteric molecules, biased signaling, and heteromerization can modulate opioid receptor effects

cyvigor

Opioid receptors are found in the human body and play a role in many physiological processes

Opioid receptors are found throughout the human body and are involved in a wide range of physiological processes. These include pain signalling in the central and peripheral nervous systems, reproduction, growth, respiration, and immunological response. Opioid receptors also play a significant role in the gastrointestinal (GI) tract, influencing both physiological and pathophysiological conditions.

Opioid receptors are a large family of receptors, including mu-opioid receptors (MORs), delta-opioid receptors (DORs), kappa-opioid receptors (KORs), and nociceptin receptors (NORs). These receptors can be found in the brain stem, spinal cord, and various brain regions. For instance, MORs are present in the dorsal horn of the spinal cord and the somatosensorial cerebral cortex, where they process nociceptive (pain) signals. The activation of these receptors by opioids can lead to a range of effects, such as depression, analgesia, constipation, and euphoria.

In the gastrointestinal tract, opioid receptors are involved in modulating circular and longitudinal muscle contractions in the ileum. Studies have shown that activation of mu and delta receptors can cause transit slowing, while kappa receptor activation has little to no effect. Additionally, morphine has been found to cause tonic and phasic increases in small intestine intraluminal pressure, possibly due to circular and/or longitudinal muscle contraction.

Opioid receptors are also implicated in the development of opioid addiction. When opioid drugs infiltrate the brain stem, they can slow respiration, cause constipation, lower blood pressure, and decrease alertness. Addiction is believed to begin in the midbrain, where opioids switch off a group of nerve cells called GABAergic neurons, which are responsible for pleasure and euphoria. Furthermore, advancements in technologies such as molecular docking and nanobodies have aided in understanding the crystal structure of opioid receptors, potentially leading to the development of novel drugs with improved efficacy and reduced adverse effects.

cyvigor

Opioid drugs bind to three major receptors: Mu, Kappa, and Delta

Opioid drugs are widely used for their analgesic properties and other related uses, such as treating coughs, diarrhoea, and mood disorders. However, their therapeutic benefits are limited by adverse effects, including the recent opioid crisis, which has resulted in an epidemic of opioid addiction and overdose.

The Kappa opioid receptor (KOR) provides analgesia, diuresis, and dysphoria. It binds to dynorphin A and B, with Prodynorphin as the precursor. The Delta opioid receptor (DOR) plays a role in analgesia and the reduction of gastric motility. It binds to enkephalins, with Proenkephalin as the precursor.

Understanding the physiological functioning of these opioid receptors is essential for developing new therapeutic drugs. For example, recent studies have shown that MORs interact with cannabinoid (CB1) receptors, increasing the potency of opioids like morphine when co-administered with THC.

cyvigor

Opioid replacement therapy swaps potent opioids for less potent compounds

Opioid receptors are found throughout the human body and are involved in several physiological processes, including pain signalling in the central and peripheral nervous systems, reproduction, growth, respiration, and immunological response. They are also present in the gastrointestinal tract, where they play a role in physiological and pathophysiological conditions.

Opioids are psychoactive analgesic drugs prescribed for pain relief and palliative care. However, due to their addictive nature, there is a risk of misuse and dependence. Opioid replacement therapy (ORT) or opioid substitution therapy (OST) is a technique used to treat opioid dependence by replacing potent and addictive opioids with less potent compounds. This approach aims to reduce the adverse health, social, and economic consequences of opioid use.

ORT involves swapping highly potent and addictive drugs, such as heroin, with compounds like methadone, buprenorphine, or naltrexone. These substitute compounds compete with heroin to bind to opioid receptors, but they do not activate the receptors to the same extent. This reduces the likelihood of an overdose. Additionally, these replacement medications remain attached to the receptors for a longer duration, helping to manage withdrawal symptoms. For example, buprenorphine binds to a receptor for 80 minutes, whereas morphine only binds for a few milliseconds.

Buprenorphine, a partial opioid agonist, is particularly effective as it only partially activates opioid receptors, making it relatively safe even in cases of overdose. It has a high affinity for opioid receptors and displaces other opioids, which can help in the treatment of opioid dependence. Naltrexone, another alternative, is a competitive opioid receptor antagonist that blocks the euphoric effects of opioids by acting on receptors in the brain.

While ORT has proven effective in reducing illicit drug use, mortality rates, criminal behaviour, and the transmission of infections like hepatitis and HIV, it is not without its challenges. Some patients need to remain on replacement medications for an extended period, and there is a lack of consensus on the most effective therapy. Additionally, some recovery communities question the approach of treating opioid addiction with different opioids.

cyvigor

Opioid receptors are involved in pain signalling in the central and peripheral nervous systems

Opioid receptors are widely distributed in the human body and are involved in several physiological processes, including pain signalling in the central and peripheral nervous systems. Opioid receptors are abundant in the central nervous system (CNS) and peripheral sensory and autonomic nerves.

The nervous system has a high concentration of opioid receptors in the periaqueductal gray, locus ceruleus (LC), rostral ventral medulla, substantia gelatinosa of the dorsal horn of the spinal cord, and the peripheral afferent nerves. The peripheral receptors sense painful stimuli, and impulses are carried to the dorsal horn of the spinal cord for relay to higher centres of the brain. Opioid drugs, such as oxycodone, bind to the mu-opioid receptor, which is responsible for the major effects of all opiates, including pain numbing (analgesia).

Opioids and their receptors are inhibitory. Rather than triggering electric pulses in our nerves, they dampen them. Opioids bind to three major receptors, called Mu, Kappa, and Delta. When opioid drugs infiltrate a part of the brain stem called the locus ceruleus, their receptors slow respiration, cause constipation, lower blood pressure, and decrease alertness.

Research on opioid receptors has led to the development of opioid receptor drug candidates with increased analgesic effects and reduced adverse effects. For example, opioid replacement therapy swaps highly potent and addictive drugs like heroin with compounds like methadone or buprenorphine, which reduce the chances of overdose.

cyvigor

Opioid receptors are found in the gastrointestinal tract and play a role in GI disorders

Opioid receptors are found throughout the human body and play a crucial role in several physiological processes, including pain signalling in the central and peripheral nervous systems, reproduction, growth, respiration, and immunological responses. They are also present in the gastrointestinal (GI) tract, where they are involved in both physiological and pathophysiological processes.

In the GI tract, opioid receptors are known to contribute to GI disorders and malfunctions, such as opioid-induced bowel dysfunction, constipation, and abdominal pain. These issues are often a result of the inhibitory effects of opioids on GI secretory activity and transit, leading to constipation and other adverse reactions. However, this property of opioids is also therapeutically exploited to manage acute and chronic diarrhoea, as well as irritable bowel syndrome with diarrhoea. Loperamide and racecadotril are two commonly used therapeutic options for these conditions.

The presence of opioid receptors in the GI tract has been studied in various animal models, including rats, guinea pigs, and mice. For example, experiments with guinea pigs have revealed the internalization of μ-opioid receptors in the myenteric plexus following abdominal surgery, indicating a role for endogenous opioids in postoperative motor disturbances. Additionally, studies in mice have shown that experimental inflammation enhances the potency of μ-opioid receptor agonists to inhibit GI transit and increases the expression of these receptors in the intestine.

The endogenous opioid system in the GI tract involves opioid peptides such as met-enkephalin, leu-enkephalin, β-endorphin, and dynorphin, which are found in both neurons and endocrine cells. When released, these opioid peptides activate opioid receptors in the enteric circuitry, regulating motility and secretion. This activation results in inhibition of gastric emptying, increased sphincter tone, induction of stationary motor patterns, and blockade of peristalsis, ultimately leading to constipation.

Carbs and Muscle: What's the Connection?

You may want to see also

Frequently asked questions

Opioid receptors are widely distributed in the human body and are involved in numerous physiological processes. While opioid receptors are present in the neural tissue of the rat enteric nervous system, they are not present in smooth muscle cells. However, specific opiate receptors have been found on isolated mammalian gastric smooth muscle cells.

Opioids have inhibitory effects on the body. They dampen electric pulses in nerve cells, preventing them from travelling through in the first place. Opioids also have a direct contractile action on circular muscle. In the brain, opioids can cause depression, analgesia, constipation, and euphoria.

Addiction begins in the midbrain, where opioids switch off a batch of nerve cells called GABAergic neurons, which are the brain's natural off-switch for euphoria and pleasure networks.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment